US EditionPublished • loading... • Updated
Gilead Sciences (NASDAQ:GILD) Given New $129.00 Price Target at Daiwa Capital Markets
Summary by themarketsdaily.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Gilead Sciences (NASDAQ:GILD) Given New $129.00 Price Target at Daiwa Capital Markets
Gilead Sciences (NASDAQ:GILD – Free Report) had its target price hoisted by Daiwa Capital Markets from $128.00 to $129.00 in a research report sent to investors on Thursday morning,MarketScreener reports. The firm currently has an outperform rating on the biopharmaceutical company’s stock. Several other research firms also recently weighed in on GILD. Citigroup upped their […]
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
